A carregar...
Experience with the Use of Nilotinib in Indian Patients
Important genetic and ethnic factors could affect the toxicity and efficacy of tyrosine kinase inhibitors. Though nilotinib has been available in India since 2010, there is no report on its safety and toxicity from Indian patients with chronic myeloid leukemia. This is an analysis of efficacy and to...
Na minha lista:
| Publicado no: | Indian J Hematol Blood Transfus |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer India
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081313/ https://ncbi.nlm.nih.gov/pubmed/30127550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-017-0877-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|